Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
David McCollum is using his interdisciplinary expertise, international networks and boundless enthusiasm to lead Oak Ridge National Laboratory’s contributions to the Net Zero World initiative.
A study by researchers at the ORNL takes a fresh look at what could become the first step toward a new generation of solar batteries.
Cement trucks entering and exiting the Spallation Neutron Source are a common sight as construction of the VENUS neutron imaging beamline progresses. Slated for completion and commissioning in 2024-2025, VENUS is the twentieth neutron instrument at SNS and will offer many new capabilities.
Energy and sustainability experts from ORNL, industry, universities and the federal government recently identified key focus areas to meet the challenge of successfully decarbonizing the agriculture sector
Neuromorphic devices — which emulate the decision-making processes of the human brain — show great promise for solving pressing scientific problems, but building physical systems to realize this potential presents researchers with a significant
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
A multidisciplinary team of scientists at ORNL has applied a laser-interference structuring, or LIS, technique that makes significant strides toward eliminating the need for hazardous chemicals in corrosion protection for vehicles.
As the United States transitions to clean energy, the country has an ambitious goal: cut carbon dioxide emissions in half by the year 2030, if not before. One of the solutions to help meet this challenge is found at ORNL as part of the Better Plants Program.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.